P&G Throws Weight Behind Consumer Growth After Shedding Pharma
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble washes its hands of prescription pharmaceuticals to focus on its consumer brands, though experts say the firm faces obstacles to growing its beauty and OTC portfolio